Are Digestive Issues a Symptom of COVID-19?

A Michigan Medicine gastroenterologist discusses the latest GI-related research from Wuhan, China.

9:00 AM

Author | Jina Sawani

Women in stomach pain

Editor's note: Information on the COVID-19 crisis is constantly changing. For the latest numbers and updates, keep checking the CDC's website. For the most up-to-date information from Michigan Medicine, visit the hospital's Coronavirus (COVID-19) webpage. 

Interested in a COVID-19 clinical trial? Health research is critical to ending the COVID-19 pandemic. Our researchers are hard at work to find vaccines and other ways to potentially prevent and treat the disease and need your help. Sign up to be considered for a clinical trial at Michigan Medicine.

A recent study conducted in Wuhan, China, and published by The American Journal of Gastroenterology, revealed that diarrhea can be an unrecognized symptom of COVID-19. The primary symptoms of the disease are generally defined as fever, cough and shortness of breath, with little research indicating gastroenterological effects associated with the condition.

The authors of the study wrote that "clinicians must bear in mind that digestive symptoms, such as diarrhea, may be a presenting feature of COVID-19, and that the index of suspicion may need to be raised earlier in these cases rather than waiting for respiratory symptoms to emerge."

The 204 patient study included individuals with an average age of 54.9 years. In addition, the study was comprised of 107 men and 97 women, with an average rate of hospital admission of 8.1 days from the initial onset of symptoms.  

These findings are really important because they emphasize the correlation between the GI tract and identifying, as well as diagnosing, COVID-19.
William Chey, M.D.

"But what is really significant about this study, is that the patients who reported digestive symptoms sought medical treatment at hospitals later than those without GI symptoms at all," says Michigan Medicine gastroenterologist William Chey, M.D., who previously served as the editor-in-chief of The American Journal of Gastroenterology. "This could simply be because some individuals might not have suspected they had COVID-19 without any respiratory symptoms."

The study also found that as the severity of the disease increased, so did the digestive symptoms, and patients devoid of any GI symptoms were more likely to be discharged from the hospital than individuals with diarrhea, nausea or anorexia.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"These findings are really important because they emphasize the correlation between the GI tract and identifying, as well as diagnosing, COVID-19," says Chey. "Another report recently came out of Wuhan, in which live virus was found in stool samples of certain patients with GI symptoms. So, it's really important for people to pay attention to their digestive systems during this pandemic, as it could literally be a matter of life or death."

Chey goes on to add that because of the recent study from Wuhan regarding the potential transmission of COVID-19 through contact with stool, it's doubly important for individuals to practice adequate hand hygiene and to avoid touching their face.

"Social distancing and thoroughly washing your hands are so crucial during this pandemic," says Chey. "When it comes to combatting COVID-19, we all have a part to play. Make sure that you do yours. We are all in this together."

This research is still early and work is still ongoing.  

Paper cited: "Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study," The American Journal of Gastroenterology.

Like Podcasts? Add the Michigan Medicine News Break to your Alexa-enabled device or subscribe for updates on iTunes, Google Play and Stitcher.


More Articles About:

Lab Report Digestive (GI) Conditions Covid-19 All Research Topics infectious disease
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Perforin increases endosomal-mitochondrial contact sites in tumor cells. Left is without perforin; right has perforin.
Health Lab

Immune system protein is a cancer killer on its own, new study shows

New study finds perforin can kill cancer tumor cells even when major granzymes were missing.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

Human Rabies Exposures Growing Across the Country

Infectious disease experts weigh in on what to do if you think you’ve been exposed to rabies.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
Two older women looking at the Medicare website on a laptop screen
Health Lab

Many older adults make Medicare decisions quickly and most don’t change plans, poll finds

Sixty percent of older adults spend less than an hour choosing their Medicare coverage during Open Enrollment, a new poll finds.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has announced it will place non-botanical products containing 7-OH on Schedule I, joining three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.